Sweden · Delayed Price · Currency is SEK Hansa Biopharma AB Statistics
Total Valuation
STO:HNSA has a market cap or net worth of SEK 3.18 billion. The enterprise value is 3.85 billion.
| Market Cap | 3.18B |
| Enterprise Value | 3.85B |
Important Dates
The last earnings date was Thursday, October 30, 2025.
| Earnings Date | Oct 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:HNSA has 101.76 million shares outstanding. The number of shares has increased by 23.22% in one year.
| Current Share Class | 101.76M |
| Shares Outstanding | 101.76M |
| Shares Change (YoY) | +23.22% |
| Shares Change (QoQ) | +19.65% |
| Owned by Insiders (%) | 5.84% |
| Owned by Institutions (%) | 17.46% |
| Float | 65.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 17.78 |
| PB Ratio | -5.66 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.00 |
| EV / Sales | 21.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.11
| Current Ratio | 1.11 |
| Quick Ratio | 1.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.87 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -42.00% |
| Return on Invested Capital (ROIC) | -70.46% |
| Return on Capital Employed (ROCE) | -175.79% |
| Revenue Per Employee | 1.28M |
| Profits Per Employee | -4.58M |
| Employee Count | 135 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 26.30 |
Taxes
In the past 12 months, STO:HNSA has paid 4.71 million in taxes.
| Income Tax | 4.71M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.80% in the last 52 weeks. The beta is 1.56, so STO:HNSA's price volatility has been higher than the market average.
| Beta (5Y) | 1.56 |
| 52-Week Price Change | -16.80% |
| 50-Day Moving Average | 34.08 |
| 200-Day Moving Average | 27.94 |
| Relative Strength Index (RSI) | 38.31 |
| Average Volume (20 Days) | 789,901 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:HNSA had revenue of SEK 178.61 million and -641.14 million in losses. Loss per share was -8.82.
| Revenue | 178.61M |
| Gross Profit | 106.22M |
| Operating Income | -565.03M |
| Pretax Income | -636.43M |
| Net Income | -641.14M |
| EBITDA | -562.68M |
| EBIT | -565.03M |
| Loss Per Share | -8.82 |
Balance Sheet
The company has 252.07 million in cash and 923.90 million in debt, giving a net cash position of -671.82 million or -6.60 per share.
| Cash & Cash Equivalents | 252.07M |
| Total Debt | 923.90M |
| Net Cash | -671.82M |
| Net Cash Per Share | -6.60 |
| Equity (Book Value) | -560.74M |
| Book Value Per Share | -6.62 |
| Working Capital | 44.46M |
Cash Flow
| Operating Cash Flow | -501.05M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 59.47% |
| Operating Margin | -316.34% |
| Pretax Margin | -356.32% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:HNSA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.22% |
| Shareholder Yield | -23.22% |
| Earnings Yield | -20.19% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |